￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Drugs for the treatment of lung cancer EGFR gene mutations: the first generation lung cancer targeted drug erlotinib

2025-10-19 11:44:20

Check Details
How much does a box of Erlotinib (Tarceva) cost after medical insurance reimbursement in 2021?

2025-10-19 11:44:20

Check Details
Will Crizotinib Capsules be included in the National Medical Insurance Directory in 2021

2025-10-19 11:44:20

Check Details
The effect of Dozerun in the treatment of patients with locally advanced or metastatic non-small cell lung cancer carrying EGFR gene mutations

2025-10-19 11:44:20

Check Details
How much does Dozerun (dacomitinib) cost per month after medical insurance in 2021?

2025-10-19 11:44:20

Check Details
Can Crizotinib Capsules be reimbursed by domestic medical insurance

2025-10-19 11:44:20

Check Details
The second-generation targeted drug for lung cancer, Dozerun, brings new options to patients with EGFR mutations

2025-10-19 11:44:20

Check Details
What to do if you vomit after taking crizotinib

2025-10-19 11:44:20

Check Details
Has the new EGFR inhibitor Dacomitinib been approved for marketing in China?

2025-10-19 11:44:20

Check Details
How much does Crizotinib capsule cost

2025-10-19 11:44:20

Check Details
Can patients with early-stage lung cancer be treated with gefitinib?

2025-10-19 11:44:20

Check Details
Pleural effusion increases after taking crizotinib

2025-10-19 11:44:20

Check Details
Category
相关知识